Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism

European Archives of Oto-Rhino-Laryngology

Volumn 268, Issue 10, 2011, Pages 1501-1504

  Rothman, Ivey N ^a   Middleton, Laura ^a   Stack Jr , Brendan C ^b,c   Bartel, Twyla ^b,c   Riggs, Ann T ^a   Bodenner, Donald L ^a,b,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UAMS Thyroid Center   (United States)

Author keywords

Hashimoto's thyroiditis; PET; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LEVOTHYROXINE; LIOTHYRONINE; THALIDOMIDE; THYROTROPIN; THYROXINE;

AGED; ELECTRONIC MEDICAL RECORD; FEMALE; FREE THYROXINE INDEX; HASHIMOTO DISEASE; HUMAN; HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; WHOLE BODY PET;

AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; HYPOTHYROIDISM; INCIDENCE; MALE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THYROID GLAND;

EID: 80052767387     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-011-1512-3     Document Type: Review

References (11)

1. SC Low AK Sinha FX Sundram 2005 Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography Singapore Med J 46 6 304 307 15902360 1:STN:280:DC%2BD2M3mtFKlug%3D%3D (Pubitemid 40756548)
2. A Van den Bruel A Maes T De Potter L Mortelmans M Drijkoningen B Van Damme P Delaere, et al. 2002 Clinical relevance of thyroid fluorodeoxyglucose- whole body positron emission tomography incidentaloma J Clin Endocrinol Metab 87 4 1517 1520 11932274 10.1210/jc.87.4.1517 (Pubitemid 34615231)
3. YK Chen HJ Ding KT Chen YL Chen AC Liao YY Shen, et al. 2005 Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects Anticancer Res 25 2B 1421 1426 15865100 (Pubitemid 40546824)
4. D King BC Stack Jr P Spring R Walker D Bodenner 2007 Thyroid carcinoma in fluorodeoxyglucose whole body positron emission tomography (PET) positive thyroid "incidentalomas" Otolaryngol Head Neck Surg 137 3 400 404 17765765 10.1016/j.otohns.2007.02.037 (Pubitemid 47320854)
5. QD Chu MS Connor DL Lilien LW Johnson RH Turnage BD Li 2006 Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center Am Surg 72 3 272 275 16553132 (Pubitemid 351837710)
6. D Karantanis TV Bogsrud GA Wiseman BP Mullan RM Subramaniam MA Nathan, et al. 2007 Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland J Nucl Med 48 6 896 901 17504869 10.2967/jnumed.106.039024 1:CAS:528:DC%2BD2sXhtVert7bE (Pubitemid 46909917)
7. OP Kimball D Marine 1992 The prevention of simple goiter in man Nutrition 8 3 200 204 1525437 1:STN:280:DyaK38zpvFyqsw%3D%3D
8. JG Hollowell NW Staehling WD Flanders, et al. 2002 Serum TSH, T (4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) J Clin Endocrinol Metab 87 489 499 11836274 10.1210/jc.87.2.489 1:CAS:528:DC%2BD38XhsVSjtbw%3D (Pubitemid 34158210)
9. BO Helal P Merlet ME Toubert B Franc C Schvartz H Gauthier-Koelesnikov, et al. 2001 Clinical impact of (18) F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131) I scanning results after therapy J Nucl Med 42 10 1464 1469 11585858 1:STN:280:DC%2BD3MrjvFSlsQ%3D%3D (Pubitemid 32953124)
10. S Kurata M Ishibashi Y Hiromatsu H Kaida I Miyake M Uchida, et al. 2007 Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis Ann Nucl Med 21 6 325 330 17705011 10.1007/s12149-007-0030-2 (Pubitemid 47283256)
11. AZ Badros E Siegel D Bodenner M Zangari J Zeldis B Barlogie G Tricot 2002 Hypothyroidism in patients with multiple myeloma following treatment with thalidomide Am J Med 112 5 412 413 11904117 10.1016/S0002-9343(01)01137-8 (Pubitemid 34246272)